“ To be uncertain is to be uncomfortable. To be certain is to be merely ridiculous. ” - Goethe

The "Improving Access to Psychological Therapies" (IAPT) initiative is very ambitious and exciting.  It states its principal aim is to support English Primary Care Trusts in implementing "National Institute for Health and Clinical Excellence" (NICE) guidelines for people suffering from depression and anxiety disorders.  It comments "The Improving Access to Psychological Therapies (IAPT) programme began in 2008 and has transformed treatment of adult anxiety disorders and depression in England. Over 900,000 people now access IAPT services each year, and the 'five year forward view for mental health' committed to expanding services further, alongside improving quality."  

“ Disagreements between scientists of good intention are merely truth in the making. ” - Andrews

Here is a mixed bag of handouts and questionnaires.  Most are spin-offs from CBASP (pronounced 'seebasp') - the awkwardly named cognitive behavioral analysis system of psychotherapy.  There are also a few handouts which are adapted downloads from the neurosciences site "The brain from top to bottom".   When in 2000, Keller et al reported on the very impressive results obtained by treating chronic depression with a mixture of CBASP and antidepressants, it seemed likely that a big step forward had been taken in improving the lot of chronic depression sufferers.  The "CBASP research results" handout (below) gives the abstracts for 14 research papers that are both relevant to CBASP and also highlight other important related themes like th

“

There is nothing the wise man does reluctantly.

” - Seneca

Here are a series of forms, questionnaires and handouts that I use regularly in my work.  The problem solving diagram is a recurring theme - both at the start of therapy and as a sheet to return to when reviewing and considering additional therapeutic options.  Other sheets are classic variants on the tools used by many cognitive behavioural therapists - with occasional alternatives and additions, that I've come up with over the years, thrown in as well.

“

Failure is simply the opportunity to begin again, this time more intelligently.

” - Henry Ford

Depression assessment scales come in two basic forms - interviewer/clinician rated and sufferer/patient rated.  As stated in the background information on the IDS/QIDS questionnaires (see below) "There are several accepted clinician rated and patient self report measures of depressive symptoms. The most commonly used clinician rated scales are the 17, 21, 24, 28, and 31 item versions of the Hamilton Rating Scale for Depression (HRSD) (Hamilton 1960, 1967), and the 10-item Montgomery-Asberg Scale (Montgomery and Asberg 1979). The most frequently used self-reports include the 13, and 21 item version of the Beck Depression Inventory (BDI) (Beck et al. 1961), the BDI-II (Beck et al. 1996), the Zung Depression Rating Scale (Zung 1965), the Carroll Rating Scale (CRS) (Carroll et al. 1981), and the Patient Health Questionnaire - 9 (PHQ-9) (Kroenke et al.

“ There is nothing so practical as a good theory. ” - Kurt Lewin

Here are a few handouts that I've put together over the years to provide background information about depression.  The development/maintenance diagram is probably the handout here that I use most - both to explain issues about depression and also for many other psychological disorders as well. 

I'm impressed by this description of personal experience with depressi

A recent study in the British Journal of Nutrition (Rogers, Appleton et al. 2008) throws doubt on the value of fish oil supplementation as a treatment for depression. The authors stated " ...

The UK National Institute for Health and Clinical Excellence is "the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and tr

Here are details and links for a couple of dozen mainly February articles that I found interesting. Most of these articles (and many others) are also listed on my searchable Connotea online database.

Barbui, C. M. D., T. A. M. D. Furukawa, et al. (2008). "Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials." CMAJ 178(3): 296-305. [Abstract/Full Text]
Blakely, T., M. Tobias, et al. (2008). "Inequalities in mortality during and after restructuring of the New Zealand economy: repeated cohort studies." BMJ 336(7640): 371-375. [Abstract/Full Text]
Bradley, R. G., E. B. Binder, et al. (2008). "Influence of Child Abuse on Adult Depression: Moderation by the Corticotropin-Releasing Hormone Receptor Gene." Arch Gen Psychiatry 65(2): 190-200. [Abstract/Full Text]

"The truth is rarely pure, and never simple"  Oscar Wilde

There has been a lot of media publicity about the article on the value of antidepressants by Irving Kirsch and colleagues which was published in PLoS Medicine last month (Kirsch, Deacon et al. 2008). The authors wrote "We obtained data on all clinical trials submitted to the US Food and Drug Administration (FDA) for the licensing of the four new-generation antidepressants for which full datasets were available. We then used meta-analytic techniques to assess ... effects of initial severity on improvement scores for drug and placebo groups and on drug-placebo difference scores." The four antidepressants studied were fluoxetine, paroxetine, nefazodone and venlafaxine.